image

Adlai Nortye - Company Information

阿诺医药(纳斯达克股票代码:ANL)是一家临床阶段的全球性生物制药公司,在中美两地均设有研发及临床运营中心,通过“联合创新”和“自主研发”的模式构建起多条全球化的产品管线,其中:AN2025(buparlisib)取得 FDA的快速通道资格,其与紫杉醇联用期望可成为治疗PD-1失败后的二线复发性或转...Read more

Biotech & Pharmaceuticals
  • icon
    Headquarters

    Hangzhou, Zhejiang, People's Republic of China

  • icon
    Contact

    Unlock contact

  • icon
    Linkedin

    linkedin icon

  • icon
    Company Size

    100 - 249

  • icon
    Stock Symbol

    N/A

  • icon
    Website

    adlainortye.com

  • icon
    Type

    N/A

icon

Adlai Nortye Technology Stack

Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by 6sense, used by Adlai Nortye

image

ASP.NET

thumbs_up

thumbs_down

ASP.net is an open source framework for building web applications and services with .NET a...

See more technologies

Adlai Nortye Employee Profiles

Are you looking for the decision-makers at Adlai Nortye? Get their email address, phone numbers, and other details from Linkedin or any website. Install and uncover Adlai Nortye’s employee details in less than 30 secs.

Sign-up for 6sense Revenue AI™ for Sales

To find emails, direct dials, and more for prospects across the web.

Sign Up Today

Adlai Nortye Competitors

Discover Adlai Nortye alternatives or similar companies to benchmark and competitors market analysis. Build a competitive intelligence sales and marketing strategy based on the data and stand out in the market.

image

Ivington CofE Primary School

  • icon
    Total Employees

    100 - 249

  • icon
    Location

    Leominster

  • icon
    Website

    ivington.hereford.sch.uk

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

Hangzhou Jiang Technology Co., Ltd.

  • icon
    Total Employees

    20 - 49

  • icon
    Location

    Hangzhou

  • icon
    Website

    jiangtechnology.com

  • icon
    Type

    Sole Proprietorship

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

FCCS

  • icon
    Total Employees

    100 - 249

  • icon
    Location

    Greenwood Village

  • icon
    Website

    fccsconsulting.com

  • icon
    Type

    Private

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

Stanton Park Capital

  • icon
    Total Employees

    0 - 9

  • icon
    Location

    Boston

  • icon
    Website

    stantonparkllc.com

  • icon
    Type

    Partnership

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

Parallax Capital Partners

  • icon
    Total Employees

    100 - 249

  • icon
    Location

    Laguna Hills

  • icon
    Website

    parallaxcap.com

  • icon
    Type

    Private

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

Download the 6sense Chrome Extension to get verified contact data of Adlai Nortye employees

Install Now
Company Logo

Adlai Nortye News & Press Releases

Sales prospecting needs to be timely and appropriate for the person and organization you are contacting. Following the most recent company news, alerts, and updates about the leads you are currently working on is the simplest and most convenient way to stay on top of them. Here are Adlai Nortye latest news, alerts and updates.

Adlai Nortye Ltd. Announces Closing of Initial Public Offering

Forward-Looking and Cautionary Statements This press release contains statements that constitute ‚ forward-looking statements,‚ including with respect to the proposed initial public offering and the concurrent private placement. No assurance can be ...

Date Icon

3 Oct 2023

Adlai Nortye Ltd. Announces Pricing of Initial Public Offering

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Sept. 29, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ANL) (the ‚ Company‚Äù or ‚ Adlai Nortye‚Äù), a clinical-stage biotechnology company focused on the development of innovative cancer therapies,

Date Icon

29 Sep 2023

IPO Update: Adlai Nortye Readies $72 Million U.S. IPO

Adlai Nortye filed for $72M IPO for its cancer drug development with a candidate in advanced stages of trials and solid financials. Learn more on ANL stock here.

Date Icon

11 Aug 2023

Adlai Nortye Ltd. Begins U.S. IPO Rollout

Adlai Nortye Ltd. has filed to raise $115 million in a U.S. IPO, although the final figure may differ. Click here for my first look at ANL IPO and its prospects.

Date Icon

31 Jul 2023

FAQs for Adlai Nortye

Explore frequently asked questions about Adlai Nortye’s business, including founding details, header quarters, information on technology stack, industry listing, and other details.

What is Adlai Nortye's official website?

The official website of Adlai Nortye is adlainortye.com You can find their contact number, email address, and headquarters by clicking here.

faq icon

How many employees are working at Adlai Nortye?

faq icon

What industry is Adlai Nortye in?

faq icon

What is Adlai Nortye's tech stack?

faq icon

Where are Adlai Nortye's headquarters?

faq icon

Get instant access to B2B contact data across the web

Sign Up Today
6sense Logo
social iconssocial iconssocial iconssocial icons
MarketingAccount IdentificationIntent DataData Enrichment & ManagementPredictive AnalyticsOrchestrations & WorkflowsAudience BuildingAdvertisingConversational EmailPipeline IntelligenceIntegrations
SolutionsBusiness ServicesFinancial ServicesTransportation & LogisticsManufacturingTechnologyCustomersMeet Our CustomersCustomer StoriesCustomer ReviewsRevCityKnowledge Base

Company

AboutLeadership TeamCareersNewsroomCommunity

Browse 6sense Data

TechnographicsComparing TechnologiesCompany SearchPeople Search
TermsPrivacy PolicyPrivacy CenterDo Not Sell or Share My Personal Information

© 2025 6sense